Navigation Links
New hydrolysis model promising tool in cellulosic biofuel studies

Scientists are working hard to develop the tools and find the organisms to break down the complex structure of plant cellulose into its component sugars the key step toward fermentation of those sugars into usable biofuel. This process needs to be simple and economically efficient before cellulosic biofuels can compete with fossil fuels for transportation energy use.

As with any exploration of systems that involve largely unknown processes, a mechanistic model can be an important first step in improved understanding. Researchers at the Energy Biosciences Institute's (EBI) laboratories on the University of California, Berkeley, campus have improved that step, bringing science closer than ever before to predicting the deconstruction activity of enzymes towards cellulose.

In a paper recently accepted by the journal Biotechnology and Bioengineering, four EBI scientists at UC Berkeley chemical engineering faculty members Doug Clark and Harvey Blanch, postdoctoral researcher Seth Levine and graduate student Jerome Fox detail their analysis that led to the most specific model to date of the enzymatic hydrolysis of cellulose.

"It's a first step in being able to have a detailed picture of what happens between cellulases (enzyme mixtures with complementary activities) and the substrate (cellulose)," said lead author Levine. Through this better understanding of the breakdown mechanisms, he said, more directed and rational approaches can be taken to engineer effective enzymes and improve the overall process of hydrolysis.

Much of the action happens at the surface of a substance like cellulose, the fibrous polysaccharide in the plant cell wall composed of hydrogen-bonded chains of the sugar glucose. Levine likens the surface to a "black box," where multiple shapes and unknown features of particles add to the complicated nature of the reactions there. Previous models relied on simple, sometimes overly broad assumptions and explained little about the chemical and physical reactions occurring there, he said.

With the EBI's latest methodology, the mechanisms by which cellulases trigger the hydrolysis of cellulose were delineated in three steps adsorption, complexation (molecular bonding) and reaction. The researchers discovered that the amount of surface area was critical for the activities of enzymes and for how well they work together in combination.

"The model explicitly tracks individual cellulases and key cellulose surface properties," the paper concludes. "Independent enzyme adsorption and complexation steps have been incorporated in an attempt to capture the most important details of the enzyme-substrate interaction. The model results illustrate the importance of understanding the effect of relevant surface areas to enzyme hydrolysis activity."

One phenomenon they tracked was the typical decline in the sugar breakdown rates after an initial "burst" phase, a reaction that usually leads to longer processing and greater enzyme loads, a costly and time-consuming step. Their research revealed a mix of surface area, structural changes within the surface, and cellulase interactivity during hydrolysis as major contributors to the slowdown. Further refinement of the model in future investigations should uncover more details.

"This work confirms that despite the complexity, enzymatic hydrolysis of cellulose is amenable to modeling," said Clark, the principal investigator for the EBI program on "Bioprocess Optimization from Cellulose Hydrolysis to Product Fermentation." "It also shows the importance of surface area, which we can control through pre-treatment (of the cellulose). There are now a lot of levers we can play with in finding an optimal enzymatic route to break cellulose down into sugars that can be converted to fuels."

Though many unknowns still remain in deciphering the complicated process that extracts sugars from plant cellulose, the EBI's mechanistic model adds a significant tool to the scientist's kit.


Contact: Ron Kolb
University of California - Berkeley

Related biology technology :

1. Campbell Alliance Sales Practice to Present at CBIs Leadership Summit on Evolving the Pharma Sales Model
2. Repligen Announces Publication of Positive Results with Proprietary HDAC Inhibitor in Huntingtons Disease Model
3. LifeModeler, Inc. Provides $400,000 Grant to InMotion Musculoskeletal Institute
4. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
5. Pigs bred with cystic fibrosis provide model to mimic human disease
6. Researchers develop new model for cystic fibrosis
7. Samaritan Partners Forgetful Rat Model to Taconic to Commercialize
8. EntreMeds ENMD-2076 Demonstrates Tumor Regression in Human Colon Cancer Model
9. Antiangiogenic Role of 2ME2 Demonstrated in Rheumatoid Arthritis Models
10. Stem Cell Sciences Licenses Stem Cell Technology to Leading Provider of Genetically Modified Models for Pharmaceutical Research
11. Sigma-Aldrich Introduces MISSION(R) In VIVO QUALITY and iScale Oligos(TM) siRNA, a Superior Quality siRNA Designed for RNAi Research in Animal Models
Post Your Comments:
(Date:11/27/2015)... 2015 /PRNewswire/--  Mallinckrodt plc (NYSE: MNK ), ... has closed the sale of its global contrast media ... Euronext) in a transaction valued at approximately $270 million. ... a total of approximately 1,000 employees spread across the ... Louis area. This entire workforce and the ...
(Date:11/27/2015)... PUNE, India , November 27, 2015 ... --> Growing popularity of companion ... emerging in cancer biomarkers market with pharmaceutical ... develop in-demand companion diagnostic tests. ... --> Complete report on global ...
(Date:11/26/2015)... November 26, 2015 --> ... specializing in imaging technologies, announced today that it has received ... of the Horizon 2020 European Union Framework Programme for Research ... clinical trial in breast cancer. , --> ... --> --> The study aims ...
(Date:11/25/2015)... 25, 2015  PharmAthene, Inc. (NYSE MKT: PIP) announced ... stockholder rights plan (Rights Plan) in an effort to ... (NOLs) under Section 382 of the Internal Revenue Code ... PharmAthene,s use of its NOLs could be substantially limited ... in Section 382 of the Code. In general, an ...
Breaking Biology Technology:
(Date:11/2/2015)... Calif. , Nov. 2, 2015  SRI International ... million to provide preclinical development services to the National ... contract, SRI will provide scientific expertise, modern testing and ... variety of preclinical pharmacology and toxicology studies to evaluate ... --> The PREVENT Cancer Drug Development Program ...
(Date:10/29/2015)... Calif. , Oct. 29, 2015  The J. ... new report titled, "DNA Synthesis and Biosecurity: Lessons Learned ... the Department of Health and Human Services guidance for ... in 2010. --> ... it also has the potential to pose unique biosecurity ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):